Skip to main content

ScholarsBetaWeill Cornell Medicine

Browse About Sign in

Loading search results…

Scholars @ Weill Cornell Medicine

Help & supportPhase 1 prototype

Loading search results…

Browse

Scholars8,803 Publications201,993 Funding7,268 Clinical research5

FiltersClear all

Status

Active, not recruiting1
Completed3
Terminated1

Study type

Interventional5
Observational1

Phase

Phase 24
Phase 31

Investigator

Jean W. Pape4
Marshall J. Glesby1

Department

Medicine5

Condition

Leukemia, Myeloid, Acute50
Prostatic Neoplasms49
Breast Neoplasms41
Heart Failure31
Neoplasms31

Intervention type

Drug5
Dietary supplement2

Sponsor type

NIH3
Cooperative group2

Start date

to

Has results posted4

Interventional×Tuberculosis×Clear all

Showing 1–5 of 5 studiesSort:

Active, not recruitingInterventional · Phase 3NCT03568383 ↗
Protecting Households On Exposure to Newly Diagnosed Index Multidrug-Resistant Tuberculosis Patients (PHOENIx MDR-TB)

Show all 50

Show fewer

Intervention: Drug: Delamanid (DLM) · Drug: Isoniazid (INH) · Dietary supplement: Pyridoxine (vitamin B6)
Dates: Jun 2019 – Nov 2026 (est.)
Sponsor: National Institute of Allergy & Infectious Diseases

Tuberculosis, MDR

CompletedInterventional · Phase 2NCT01936831 ↗

The Early Bactericidal Activity of High-Dose or Standard-Dose Isoniazid Among Adult Participants With Isoniazid-Resistant or Drug-Sensitive Tuberculosis

Intervention: Drug: Isoniazid · Dietary supplement: Vitamin B6
Dates: Aug 2014 – Sep 2021· Results posted
Sponsor: National Institute of Allergy & Infectious Diseases

Tuberculosis

CompletedInterventional · Phase 2NCT03819114 ↗

An Open-Label, Phase II Pharmacokinetic Study to Evaluate Double-Dose Levonorgestrel Emergency Contraception in Combination With Efavirenz-Based Antiretroviral Therapy or Rifampicin-Containing Anti-Tuberculosis Therapy

Marshall J. GlesbyPI

Intervention: Drug: Levonorgestrel (LNG)
Dates: May 2019 – Nov 2020· Results posted
Sponsor: AIDS Clinical Trial Group

HIV InfectionsTuberculosis

TerminatedInterventional · Phase 2NCT04311502 ↗

A Phase IIc Trial of Clofazimine- and Rifapentine-Containing Treatment Shortening Regimens in Drug-Susceptible Tuberculosis: The CLO-FAST Study

Intervention: Drug: Rifapentine · Drug: Rifampicin · Drug: Isoniazid · Drug: Pyrazinamide · Drug: Ethambutol · Drug: Clofazimine loading dose · Drug: Clofazimine 100 MG
Dates: Nov 2021 – Jun 2024· Results posted
Sponsor: National Institute of Allergy & Infectious Diseases

HIVTuberculosis

CompletedInterventional · Phase 2NCT05007821 ↗

A Phase II, Prospective, Randomized, Multicenter Trial to Evaluate the Efficacy and Safety/Tolerability of Two Linezolid Dosing Strategies in Combination With a Short Course Regimen for the Treatment of Drug-Resistant Pulmonary Tuberculosis

Intervention: Drug: Linezolid 600 mg · Drug: Linezolid 1200 mg (QD) · Drug: Linezolid 1200 mg (TIW) · Drug: Bedaquiline 200 mg · Drug: Bedaquiline 100 mg · Drug: Delamanid 300 mg · Drug: Clofazimine 300 mg · Drug: Clofazimine 100 mg
Dates: Sep 2022 – Mar 2025· Results posted
Sponsor: AIDS Clinical Trial Group

Tuberculosis, Multidrug-ResistantTuberculosisTuberculosis, Pulmonary